We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$39.9B
1-Year Est. Return
29.7%
This Fund
S&P 500
This Quarter
Est. Return
+3.75%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$11.5B
AUM Growth
+$676M
(+6.2%)
Cap. Flow
+$423M
Cap. Flow
% of AUM
3.68%
Top 10 Holdings %
Top 10 Hldgs %
16.08%
Holding
1,352
New
79
Increased
457
Reduced
417
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$74.5M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$42.7M |
| 3 |
WUBA
58.com Inc
WUBA
|
+$39M |
| 4 |
CDK
CDK Global, Inc.
CDK
|
+$36.6M |
| 5 |
Akamai
AKAM
|
+$35.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$52.2M |
| 2 |
Boeing
BA
|
+$47.4M |
| 3 |
Honeywell
HON
|
+$43.6M |
| 4 |
Microsoft
MSFT
|
+$33.8M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$30.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.33% |
| 2 | Financials | 17.82% |
| 3 | Healthcare | 13.36% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Industrials | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOC
1201
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $87K | ﹤0.01% |
5,448
-2,687
| -33% | -$40.6K |
|
1202
Ennis
EBF
$554M
| $80K | ﹤0.01% |
3,938
| – | – |
|
1203
Cibus
CBUS
$148M
| $75K | ﹤0.01% |
80
| – | – |
|
1204
CRISPR Therapeutics
CRSP
$4.69B
| $71K | ﹤0.01% |
1,200
-500
| -29% | -$28.5K |
|
1205
AstraZeneca
AZN
$269B
| $70K | ﹤0.01% |
+1,000
| New | +$71.9K |
|
|
DVAX
1206
DELISTED
Dynavax Technologies
DVAX
| $69K | ﹤0.01% |
4,500
| – | – |
|
|
DHC
1207
Diversified Healthcare Trust
DHC
$2.15B
| $66K | ﹤0.01% |
3,636
-9,033
| -71% | -$149K |
|
1208
Agilysys
AGYS
$3.21B
| $63K | ﹤0.01% |
4,068
+2,121
| +109% | +$28.1K |
|
1209
Cal-Maine
CALM
$4.43B
| $63K | ﹤0.01% |
1,380
| – | – |
|
1210
JetBlue
JBLU
$2.13B
| $62K | ﹤0.01% |
3,251
-665
| -17% | -$12.8K |
|
|
SNCR
1211
DELISTED
Synchronoss Technologies
SNCR
| $61K | ﹤0.01% |
1,107
+559
| +102% | +$54.4K |
|
|
DSPG
1212
DELISTED
DSP Group Inc
DSPG
| $59K | ﹤0.01% |
+4,752
| New | +$58.2K |
|
1213
International Bancshares
IBOC
$4.77B
| $58K | ﹤0.01% |
1,350
+115
| +9% | +$4.83K |
|
1214
NETGEAR
NTGR
$612M
| $58K | ﹤0.01% |
924
-97
| -10% | -$5.89K |
|
1215
LiveRamp
RAMP
$2.29B
| $58K | ﹤0.01% |
1,935
| – | – |
|
1216
Editas Medicine
EDIT
$399M
| $57K | ﹤0.01% |
1,600
| – | – |
|
1217
Gevo
GEVO
$353M
| $56K | ﹤0.01% |
14,720
| – | – |
|
|
MRNS
1218
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $56K | ﹤0.01% |
1,963
| – | – |
|
1219
Benchmark Electronics
BHE
$2.66B
| $55K | ﹤0.01% |
1,902
+314
| +20% | +$9.02K |
|
1220
Ciena
CIEN
$46.8B
| $55K | ﹤0.01% |
2,092
-269
| -11% | -$6.83K |
|
1221
Plexus
PLXS
$6.43B
| $55K | ﹤0.01% |
917
-4
| -0.4% | -$239 |
|
|
AHL
1222
DELISTED
ASPEN Insurance Holding Limited
AHL
| $51K | ﹤0.01% |
1,256
-57
| -4% | -$2.46K |
|
|
LPNT
1223
DELISTED
LifePoint Health, Inc.
LPNT
| $51K | ﹤0.01% |
1,045
| – | – |
|
1224
Future Fuel
FF
$205M
| $50K | ﹤0.01% |
+3,594
| New | +$46.3K |
|
1225
Jakks Pacific
JAKK
$303M
| $49K | ﹤0.01% |
1,509
-421
| -22% | -$11.2K |
|
Similar funds
HF
KBC Group's Q2 2018 Portfolio in Review
As of Q2 2018, KBC Group held 1,352 positions worth $11.5B, up 6.2% from $10.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
KBC Group deployed $423M of net new capital in Q2 2018, opening 79 new positions and adding to 457 existing holdings. Its largest new stake was Broadcom: 432,730 shares worth $10.5M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was AbbVie, an estimated $52.2M trimmed.
- KBC Group's largest Q2 2018 buy was Broadcom: 432,730 shares worth $10.5M.
- KBC Group added most to Cisco in Q2 2018, an estimated $74.5M increase.
- KBC Group's biggest Q2 2018 reduction was AbbVie, cutting an estimated $52.2M.
- KBC Group fully exited Time Warner Inc in Q2 2018, selling an estimated $30.3M.
- KBC Group's ten largest holdings make up 16% of its $11.5B portfolio in Q2 2018.
- KBC Group opened 79 new positions and closed 64 in Q2 2018.
- KBC Group's portfolio value rose 6.2% quarter-over-quarter to $11.5B.
Based on KBC Group's 13F filing for Q2 2018, filed 3 Aug 2018.